Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Abstract: The present application provides a gas alarm replacement warning method and device, and an electronic apparatus including the device. The method is applied to a gas alarm including a gas-sensitive element. The method includes: collecting signal data of the gas alarm; analyzing the current use state of the gas alarm based on the signal data; determining a dynamic model of the expected service life of the gas alarm according to the current use state, and calculating the expected use duration of the gas alarm; determining whether the actual use duration of the gas alarm is greater than the expected use duration; and if so, outputting a replacement prompt signal. Therefore, based on the expected service life of the gas alarm, when the use duration of the gas alarm approaches the expected service life, a replacement prompt signal is issued to solve the problem of untimely replacement of the gas alarm and ensure the safety of indoor gas use.

Abstract: The present application provides a gas alarm replacement warning method and device, and an electronic apparatus including the device. The method is applied to a gas alarm including a gas-sensitive element. The method includes: collecting signal data of the gas alarm; analyzing the current use state of the gas alarm based on the signal data; determining a dynamic model of the expected service life of the gas alarm according to the current use state, and calculating the expected use duration of the gas alarm; determining whether the actual use duration of the gas alarm is greater than the expected use duration; and if so, outputting a replacement prompt signal. Therefore, based on the expected service life of the gas alarm, when the use duration of the gas alarm approaches the expected service life, a replacement prompt signal is issued to solve the problem of untimely replacement of the gas alarm and ensure the safety of indoor gas use.

Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Abstract: Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids.

Abstract: Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids.

Abstract: Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids.

Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Abstract: Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids.

Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Abstract: Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids.

Abstract: A system and method for enterprise search includes one or more computer-readable media storing computer-executable instructions that, when executed on one or more processors that perform acts including extracting one or more of term data, personal data and metadata from one or more predetermined resources; retrieving a set of information derived from the extracted term data, personal data and metadata responsive to a query; and receiving feedback responsive to the set of information, the feedback augmenting at least one of the one or more predetermined resources.

Abstract: Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids.

Abstract: A system and method for enterprise search includes one or more computer-readable media storing computer-executable instructions that, when executed on one or more processors that perform acts including extracting one or more of term data, personal data and metadata from one or more predetermined resources; retrieving a set of information derived from the extracted term data, personal data and metadata responsive to a query; and receiving feedback responsive to the set of information, the feedback augmenting at least one of the one or more predetermined resources.

Abstract: Described herein are oral pharmaceutical compositions suitable for chewing, sucking, or buccal dissolution comprising soft gel capsules and liquid fills, methods for making the same, and methods for treating subjects in need thereof with such capsules. In particular, oral pharmaceutical compositions comprising chewable, suckable, or dissolvable soft gel capsules with various flowable fill compositions are described.

Abstract: An inflatable lifesaving device is designed to provide a user with an apparatus to escape a high rise building in emergency situations in a sufficiently rapid manner. It is simply composed of a hemisphere including a plurality of independent cell airbags, internal hoses, and check valves, a parachute integrated with the hemisphere, an air supply system, an external hose, a quick release hose coupler, a harness mounted on the body of the user, a connection rope that connects the harness to the inside of the building, a rope quick release to separate the connection rope, a descent rope, a backpack. To operate the inflatable lifesaving device, the user wearing the harness with the backpack exits a window or a balcony with the harness connected to the inside of the building through the connection rope with the release device.

Abstract: The techniques described herein automatically generate high precision clusters and high recall clusters for a set of documents having an author with a same or similar name. The high precision clusters and the high recall clusters can then be used in a labeling process so that efficient and accurate author disambiguation is realized.

Abstract: Described herein are soft capsules and enteric soft capsules comprising cationic Type A gelatin and acid insoluble enteric polymers. In particular, the compositions and methods for manufacturing all-natural enteric soft capsules comprising Type A gelatin and matrix fills are described. In one embodiment, the enteric soft capsules comprise active ingredients such as non-steroidal anti-inflammatory drugs (NSAIDs). In another embodiment, the enteric soft capsule comprises matrix fills of omega-3 fatty acids.